|
|
|
Donald's Story
Prostate Cancer
During a physical examination by my primary care
physician, a rise in my PSA count was noted. This
exam took place in November, 2003. I was referred
to a Urologist for further evaluation.
The resulting examination and X-ray revealed a
fairly normal prostate both in size and shape;
however, further testing confirmed a PSA count of
4.3 which resulted in biopsies being performed at
that time. On January 7, 2004, I was notified of
prostate cancer being noted on my left prostate
with some cloudiness surrounding this organ. This
condition could lead to further problems in the
future.
My options included surgery, seed implanting,
external radiation, and the utilization of the
CyberKnife. I had been a CyberKnife patient three
years earlier having been successfully treated
for an Acoustic Neuroma and I know this
alternative treatment was now being used in lower
body extremities. In my on-going search for the
best way for me to proceed, I realized the lack
of more available data regarding the CyberKnife
was a stumbling block for other physicians who
recommended the seed implanting.
I became the 4th patient treated at Stanford
University for prostate cancer with the
CyberKnife. I chose this method as it was the
most non-invasive and posed the least amount of
adversarial effects after the treatment. I also
had the utmost confidence in both the treatment
and physician. The treatment was spread out over
five days with an hour spent per treatment. The
immediate after effects were totally negative
although I did experience some side effects two
weeks out of the final treatment date. Those
effects are temporary and pose nothing but an
inconvenience without any serious discomfort or
pain. Within two months or less, there are not
any other signs or residual effects from the
CyberKnife treatment.
My 90 day window of further testing indicated a
reduced PSA score of 1.9 and we anticipate
further reduction within the next 90 day window.
I definitely recommend this procedure for Prostate Cancer.
|
|